Analysis of the Medicinal Properties, Efficacy, and Application of Chinese Medicines in the 2020 Edition of Chinese Pharmacopoeia
College of Traditional Chinese Medicine and Health, Nanfang College, Guangzhou 510970, China
| Abstract: | Objective: "Medicinal herbs and decoction pieces" in the 2020 edition of Chinese Pharmacopoeia (Part 1) includes a total of 616 items of traditional Chinese medicine. This study is aimed to grasp the overview of all traditional Chinese medicine and discover special ones. Methods: This study conducted statistical analysis of their basic information such as the properties, efficacy, application, dosage and usage. Results: The Chinese Pharmacopoeia has 9 descriptions of the four properties, with the highest number of warm medicines. For the five flavors, the number of bitter medicines is the highest. For meridian tropism, the liver-channel medicines are the majority. Huanglian with 6 meridians is the Chinese medicine with the most meridian tropism. For toxicity, a total of 83 traditional Chinese medicines has clear toxicity descriptions, divided into three levels: "with high toxicity", "toxic", and "with low toxicity". For efficacy, the "heat clearing" effect is the majority. Hongqi and Huangqi are the medicines with the most efficacy. For application, the frequency of "swelling and pain" is the highest. Huanglian is the medicine with the most applications. For the dosage, the average is 6-13g. The minimum value is 0.015g of Chansu and the maximum one is 120g of Maozhaocao. Moreover, the weakening of the "traditional Chinese medicine" characteristics in certain individual herbs and the inadequacy in the description of ethnopharmacological drugs were observed. Additionally, limitations were identified in the representation of toxicity and dosage for external use, which failed to adequately integrate modern toxicological and clinical data. Conclusion: This study reveals the basic information overview of traditional Chinese medicines in the Chinese Pharmacopoeia regarding their four properties, five flavors, meridian tropism, toxicity, therapeutic indications, dosage, and administration methods. It showcases the uniqueness in the description of some traditional Chinese medicines and points out issues such as the insufficient "traditional Chinese medicine" characteristics in certain varieties, the need for improvement in compilation standardization, and the ambiguity in dosage for external use. |
| Keywords: | Chinese Pharmacopoeia; Properties and Tastes and Meridian Tropism; Efficacy and Application; Usage and Dosage |
| DOI: | 10.57237/j.cmrd.2024.03.001 |
View:
Downloads:
Received: 2 September 2024
Accepted: 24 September 2024
Published Online: 26 October 2024
References
| [1] | 国家药典委员会. 中华人民共和国药典. 一部[M]. 北京: 中国医药科技出版社, 2020. |
| [2] | 王赛, 白明, 李秀敏等. 2020年版《中国药典》 (一部) 叶类中药功能及应用分析 [J]. 中药药理与临床, 2022, 38(1): 191-195. |
| [3] | 田硕, 苗明三, 熊维政等.2020年版《中国药典》 (一部) 药材和饮片的外用功能及应用分析 [J]. 中国实验方剂学杂志, 2021, 27(8): 161-167. |
| [4] | 孟驿佳, 康乐, 王媛等. 2020年版《中国药典》 (一部) 有毒中药毒性成分及毒性特点分析 [J]. 中药药理与临床, 2023, 39(1): 99-104. |
| [5] | 高元峰, 王瑞颖, 易柳等.中国药典2020年版 (一部) 收载毒性中药及其注意事项统计分析 [J]. 中国药师, 2021, 24(6): 1133-1137. |
| [6] | 高梅, 张婷婷, 曲蒙蒙等. 榼藤子的现代研究进展及质量标志物预测分析 [J]. 中国现代中药, 2023, 25(5): 1125-1134. |
| [7] | 熊竞争, 李翔, 陈博等.彝、藏、壮、蒙医药治疗皮肤病研究概况 [J]. 中国民族民间医药, 2023, 32(12): 52-57. |
| [8] | 唐策, 干志强, 罗世英等.基于血清代谢组学的藏族药翼首草提取物治疗类风湿性关节炎的作用机制研究 [J]. 中国中药杂志, 2022, 47(4): 1001-1008. |
| [9] | 钟赣生, 杨柏灿. 中药学 [M]. 北京: 中国中医药出版社, 2021. |
| [10] | 尕藏加措, 索朗次仁. 浅析藏药基础理论 [J]. 中华中医药杂志, 2022, 37(12): 7462-7464. |
| [11] | 何文静. 维吾尔药药性药味补遗和维医异黑胆质证方剂配伍规律研究 [D]. 北京中医药大学, 2020. |
| [12] | 刘广运, 白莉, 苗明三.2020版《中国药典》42种有毒中药外用特点分析 [J/OL]. 中药药理与临床: 1-18. |
| [13] | 徐麟, 颜冬梅, 聂鹤云等. 基于2020年版中国药典毒性药材标准现状对中药毒性分级标准的思考与探讨 [J]. 中药材, 2021, 44(5): 1041-1045. |
| [14] | WANG J, WANG L, LOU G H, et al. Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology [J]. Pharmaceutical Biology, 2019, 57(1), 193-225. |
| [15] | HE L, ZHONG Z, CHEN M, et al. Current advances in Coptidis Rhizoma for gastrointestinal and other cancers [J]. Frontiers in pharmacology, 2022, 12, 775084. |
| [16] | 牛克.中药材日常贮存中的对抗同贮法研究与应用[J].黑龙江中医药, 2020, 49(3): 147. |
| [17] | 国家药品监督管理局. 国家药监局关于发布《中药注册分类及申报资料要求》的通告[EB/OL] (2020-09-28) [2024-04-25]. https://www.nmpa.gov.cn/directory/web/nmpa///xxgk/ggtg/ypggtg/ypqtggtg/20200928164311143.html |
| [18] | 杨平, 阳长明. 建立完善符合中药特点的中药药学研究技术指导原则体系 [J]. 中国现代中药, 2020, 22(12): 1951-1956. |
| [19] | 毕经正, 张效霞. 现代 “中医”概念的形成 [J]. 中华中医药杂志, 2022, 37(2): 975-978. |
Join the Editorial Board
We invite active, qualified and high profile scientists and researchers to join as Editorial Board Members.
Join UsBecome a Reviewer
Scholars with a strong interest in reviewing are invited to join the reviewer panel to ensure the quality of the research to be published.
Join Us